Your browser doesn't support javascript.
loading
Evaluation of the Safety of Drugs and Biological Products Used During Lactation: Workshop Summary.
Wang, J; Johnson, T; Sahin, L; Tassinari, M S; Anderson, P O; Baker, T E; Bucci-Rechtweg, C; Burckart, G J; Chambers, C D; Hale, T W; Johnson-Lyles, D; Nelson, R M; Nguyen, C; Pica-Branco, D; Ren, Z; Sachs, H; Sauberan, J; Zajicek, A; Ito, S; Yao, L P.
Afiliación
  • Wang J; Office of Drug Evaluation IV, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
  • Johnson T; Division of Pediatric and Maternal Health, Office of Drug Evaluation IV, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
  • Sahin L; Division of Pediatric and Maternal Health, Office of Drug Evaluation IV, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
  • Tassinari MS; Division of Pediatric and Maternal Health, Office of Drug Evaluation IV, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
  • Anderson PO; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, California, USA.
  • Baker TE; Infantrisk Center, Texas Tech University Health Sciences Center Amarillo, Amarillo, Texas, USA.
  • Bucci-Rechtweg C; Novartis Pharmaceuticals Corporation, One Health Plaza, East Hanover, New Jersey, USA.
  • Burckart GJ; Office of Clinical Pharmacology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
  • Chambers CD; School of Medicine, University of California San Diego, La Jolla, California, USA.
  • Hale TW; Infantrisk Center, Texas Tech University Health Sciences Center Amarillo, Amarillo, Texas, USA.
  • Johnson-Lyles D; Division of Pediatric and Maternal Health, Office of Drug Evaluation IV, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
  • Nelson RM; Office of Pediatric Therapeutics, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
  • Nguyen C; Division of Bone, Reproductive, and Urologic Products, Office of Drug Evaluation III, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
  • Pica-Branco D; Division of Pediatric and Maternal Health, Office of Drug Evaluation IV, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
  • Ren Z; Obstetric and Pediatric Pharmacology and Therapeutics Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institute of Health, Bethesda, Maryland, USA.
  • Sachs H; Division of Pediatric and Maternal Health, Office of Drug Evaluation IV, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
  • Sauberan J; Neonatal Research Institute, Sharp Mary Birch Hospital for Women and Newborns, San Diego, California, USA.
  • Zajicek A; Obstetric and Pediatric Pharmacology and Therapeutics Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institute of Health, Bethesda, Maryland, USA.
  • Ito S; Division of Clinical Pharmacology & Toxicology, Department of Pediatrics, Hospital For Sick Children, Toronto, Ontario, Canada.
  • Yao LP; Division of Pediatric and Maternal Health, Office of Drug Evaluation IV, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
Clin Pharmacol Ther ; 101(6): 736-744, 2017 Jun.
Article en En | MEDLINE | ID: mdl-28510297
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Productos Biológicos / Lactancia Materna / Lactancia / Conferencias de Consenso como Asunto / Exposición Materna / Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos Tipo de estudio: Etiology_studies / Guideline / Prognostic_studies / Qualitative_research / Risk_factors_studies Límite: Female / Humans / Infant / Newborn / Pregnancy Idioma: En Revista: Clin Pharmacol Ther Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Productos Biológicos / Lactancia Materna / Lactancia / Conferencias de Consenso como Asunto / Exposición Materna / Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos Tipo de estudio: Etiology_studies / Guideline / Prognostic_studies / Qualitative_research / Risk_factors_studies Límite: Female / Humans / Infant / Newborn / Pregnancy Idioma: En Revista: Clin Pharmacol Ther Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos